咨询与建议

限定检索结果

文献类型

  • 2 篇 期刊文献

馆藏范围

  • 2 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 2 篇 医学
    • 2 篇 临床医学
    • 1 篇 药学(可授医学、理...
  • 1 篇 哲学
    • 1 篇 哲学
  • 1 篇 理学
    • 1 篇 生物学
  • 1 篇 管理学
    • 1 篇 公共管理

主题

  • 1 篇 chloroquine
  • 1 篇 patients
  • 1 篇 acute
  • 1 篇 off-label
  • 1 篇 covid-19
  • 1 篇 respiratory
  • 1 篇 hydroxychloroqui...

机构

  • 1 篇 department of re...
  • 1 篇 department of re...
  • 1 篇 deparment of car...
  • 1 篇 department of pu...
  • 1 篇 instiute of medi...
  • 1 篇 advanced institu...
  • 1 篇 peking universit...
  • 1 篇 trauma center pe...
  • 1 篇 research center ...
  • 1 篇 beijing haidian ...
  • 1 篇 department of re...
  • 1 篇 drug clinical tr...
  • 1 篇 deparment of res...
  • 1 篇 department of et...

作者

  • 1 篇 yudong wei
  • 1 篇 chunli song
  • 1 篇 haiyan li
  • 1 篇 ni-ni dai
  • 1 篇 fei xu
  • 1 篇 qiu-yu li
  • 1 篇 haichao li
  • 1 篇 ning shen
  • 1 篇 yu zhang
  • 1 篇 hua zhang
  • 1 篇 jianping zhao
  • 1 篇 li-jun liang
  • 1 篇 yahong chen
  • 1 篇 xiaoye niu
  • 1 篇 jie qiao
  • 1 篇 xue hong
  • 1 篇 nan li
  • 1 篇 na liu
  • 1 篇 qiuyu li
  • 1 篇 jianping dong

语言

  • 2 篇 英文
检索条件"基金资助=Peking University Health Center Foundation for Combating the Pandemic Programs"
2 条 记 录,以下是1-10 订阅
排序:
Ethical review of off-label drugs during the COVID-19 pandemic
收藏 引用
World Journal of Clinical Cases 2022年 第17期10卷 5541-5550页
作者: Qiu-Yu Li Ye Lv Zhuo-Yu An Ni-Ni Dai Xue Hong Yu Zhang Li-Jun Liang Department of Pulmonary and Critical Care Medicine Peking University Third HospitalBeijing 100191China Advanced Institute for Medical Sciences Dalian Medical UniversityDalian 116044Liaoning ProvinceChina peking university Institute of Hematology Peking University People’s HospitalBeijing 100191China Department of Ethics Office Peking University Third HospitalBeijing 100191China
High-quality scientific research is very important in attempting to effectively control the coronavirus disease 2019(COVID-19)pandemic and ensure people’s health and ***(CQ)and hydroxychloroquine(HCQ)have received mu... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论
Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
收藏 引用
Science China(Life Sciences) 2021年 第4期64卷 660-663页
作者: Qiuyu Li Cheng Cui Fei Xu Jianping Zhao Nan Li Haichao Li Tianbing Wang Hua Zhang Na Liu Yudong Wei Xiaoye Niu Yan Xu Jianping Dong Xueting Yao Xiaohong Wang Yahong Chen Haiyan Li Chunli Song Jie Qiao Dongyang Liu Ning Shen Department of Respiratory and Critical Care Medicine Peking University Third HospitalBeijing 100191China Drug Clinical Trial center Peking University Third HospitalBeijing 100191China Deparment of Respiratory and Critical Care Medicine the First Afiliated Hospital of Nanchang UniversirNanchang 300060 China Department of Respiratory and Critical Care Medicine Tongi HospitalTongii Medical CollegeHuazhong Universiy of Science and TechnologyWuhan 430030China Research center of Clinical Epidemiology Peking University Third HospitalBejing 100191China Department of Respiratory and Critical Care Medicine Peking University First HospitalBeijing 100034China Trauma center Peking University People's HospitalBeijing 100044China Beijing Haidian Hospital Haidian Section of Peking University Third HospitalBeijing 100080Chima Deparment of Cardiology peking university Third Hospital Beijing 100191China Instiute of Medical Innovation Peking University Third HospitalBejing 100191China
Dear Editor,Since December 2019,severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has been rapidly spreading *** and chloroquine are candidates for the treatment of coronavirus disease 2019(COVID-19)owing to ... 详细信息
来源: 维普期刊数据库 维普期刊数据库 同方期刊数据库 同方期刊数据库 评论